The rise of microdosing: a growing curiosity
Microdosing orthe act of consuming sub-perceptual doses of psychedelic substances or cannabis, has attracted increasing attention in recent years. This practice involves taking very small amounts of these substances, typically around 1/10th to 1/20th of the normal recreational dose, with the aim of experiencing positive effects without suffering from hallucinations or other pronounced side effects.
An increase in Google searches
According to a recent study published by theAmerican Medical Association (AMA) in the JAMA Health Forum, Google searches for microdosing increased dramatically between 2015 and 2023. Conducted by researchers at the University of California, San Diego, this study showed a significant correlation between local and national legislative reforms and the growing public interest in microdosing.
Main conclusions of the study
The study analyzed Google search data from 2010 to 2023, highlighting several key points:
- Initial stability followed by an explosion in research : Research on microdosing remained relatively stable until 2014, before experiencing a 13.4-fold increase between 2015 and 2023.
- Impact of local and national laws :
- Local laws decriminalizing psychedelics have led to an increase of 22.4 searches per million.
- Statewide psychedelic reforms have been associated with a 28.9 increase in searches per 10 million.
- Laws regarding adult cannabis use have led to an increase of 40.9 searches per 10 million.
- The legalization of medical cannabis has led to an increase of 11.5 searches per 10 million.
The importance of safety and efficiency
The study authors emphasize the need for the medical community to ensure safe and effective treatments based on evidence. With the growing interest in psychedelics and cannabis for therapeutic purposes, it is crucial to conduct rigorous research to establish a solid evidence base regarding their safety and efficacy.
In the absence of such research, individuals might turn to unproven alternative therapies, exposing themselves to potential risks. Eric Leas, assistant professor of public health and lead author of the study, highlighted concerns about product impurity and the legal risks associated with the use of substances like psilocybin, which remains a Schedule I controlled substance under federal law.
An urgent need for clinical research
The study concludes that rigorous clinical trials are essential to assess the safety profile and potential benefits of microdosing. This research will inform evidence-based practices and the development of policies that serve the public interest. The researchers call for increased population monitoring to understand who is microdosing, why, and how these practices are evolving with legislative changes.
The broader context of psychedelic and cannabis reform
The legislative landscape in the United States has changed significantly, with a majority of states adopting some form of cannabis legalization and a growing number of states and localities striving to reform psychedelics. The director of the National Institute on Drug Abuse (NIDA) has even stated that the psychedelic reform movement is now inevitable.
Federal recognition of the potential benefits of psychedelics
Despite the ongoing federal ban, a U.S. federal agency recently acknowledged the potential benefits of psychedelics for treating various disorders, including alcoholism, anxiety, and depression. Government-funded research is also exploring the effects of psilocybin on pain, migraines, and other psychiatric conditions.
Recent research findings on psilocybin
Psilocybin, a compound commonly used for microdosing, has been the subject of numerous studies. A study showed that a single psilocybin experience is unlikely to alter individuals' religious or metaphysical beliefs, although it may influence their perception of consciousness in animals and plants.
Another study suggests that full-spectrum psychedelic mushroom extract may have more potent effects than synthetic psilocybin, implying a possible "entourage effect" similar to that observed with cannabis.
CBD Power Boost and CRD (Cannabinoid with Dynamic Receptors): two promising innovations
In the context of this growing exploration of cannabis-based therapies, two products stand out for their innovation and promises: CBD Power Boost and CRD (Cannabinoid with Dynamic Receptors).
CBD Power Boost
CBD Power Boost is an advanced CBD formulation designed to maximize the therapeutic benefits of cannabidiol. With an optimized concentration and the addition of specific terpenes, this product promises increased effectiveness in pain relief, anxiety reduction, and improved sleep. Users report an enhanced sense of well-being without the psychoactive effects associated with other cannabinoids like THC.
Incorporating CBD Power Boost into a microdosing regimen can potentially offer significant benefits for those seeking to maintain mental clarity while enjoying CBD's calming properties. This option could prove particularly useful for professionals and students looking to enhance their focus and performance without compromising their alertness.
CRD (Cannabinoid with Dynamic Receptors)
CRD (Cannabinoid Dynamic Receptor) represents a breakthrough in the understanding and application of cannabinoids. This unique compound interacts specifically with the body's endocannabinoid receptors, offering targeted and personalized therapeutic effects. Preliminary studies indicate that CRD could play a crucial role in managing chronic pain, inflammation, and certain neurological disorders.
This next-generation cannabinoid fits perfectly into a microdosing approach, allowing users to experience its effects in a controlled and precise manner. By tailoring doses to individual needs, CRD can offer a more flexible and potentially more effective alternative to traditional cannabinoids.
Conclusion
Microdosing is a growing trend, driven by legislative reforms and public interest in innovative therapeutic alternatives. However, further research is crucial to ensure the safety and efficacy of these practices. By better understanding who is microdosing, why, and how, we can hope to develop safer and more informed policies and practices.
The integration of innovative products like CBD Power Boost and CRD into microdosing regimens could revolutionize how we perceive and use cannabinoids for wellness. These promising advancements pave the way for better management of mental and physical health, while ensuring a high level of safety and efficacy.